Sfoglia per Rivista HAEMATOLOGICA
Failure of late intensification therapy combining cytosine-arabinoside + thioguanine in reduce the risk of relapse off-therapy in childhood acute lymphocitic leukemia (ALL).
1983 Meloni, Giovanna; ALOE SPIRITI, Maria Antonietta; S., Amadori; Giona, Fiorina
Fatty acid oxidation and metabolic targeting of leukemia cells by the CPT1 inhibitor ST1326
2013 Mirabilii, Simone; Ricciardi, Maria Rosaria; Allegretti, Matteo; Licchetta, Roberto; M., Vincenzi; G., Peluso; R., Nicolai; Foà, R.; Tafuri, Agostino
Feasibility and safety of a new technique of extracorporeal photochemotherapy: Experience of 240 procedures
1999 Perotti, C.; Torretta, L.; Viarengo, G.; Roveda, L.; Bernuzzi, S.; Carbone, S.; Del Fante, C.; La Torre, R.; Locatelli, F.; Bonetti, F.; Gabba, P.; Bellosta, M.; Salvaneschi, L.
Flow cytometric analysis of the TCR V-beta repertoire in mature T-cell expansions.
2005 De Propris, Ms; DELLA STARZA, Irene; Milani, L; DEL GIUDICE, Ilaria; Santangelo, S; Anaclerico, B; Calabrese, E; Mancini, F; Foà, R; Guarini, A.
Flow cytometric measurement (H-1 Technicon) of microcytic and hyperchromic red cell populations in pediatric patients affected by hereditary spherocytosis (HS)
1989 Ialongo, Pierluigi; Vignetti, Marco; Cigliano, G; Amadori, S; Mandelli, Franco
FLT3 positive acute myeloid leukemia: A single center experience
2007 V., Gianfelici; S., Capria; L., Cardarelli; Cimino, Giuseppe; D., Diverio; A. P., Iori; M., Nanni; M., Ribersani; S. M., Trisolini; Foa, Roberto; Meloni, Giovanna
FLT3-ITD ABNORMALITIES AND COMORBIDITIES AS INDEPENDENT PROGNOSTIC INDICATORS OF SURVIVAL IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
2009 Breccia, M; Cannella, L.; Latagliata, R.; Diverio, D.; Minotti, C.; Cartoni, C.; Stefanizzi, C.; Loglisci, G.; Nanni, M.; Cimino, G.; Alimena, G.
FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis.
2013 Breccia, M; Loglisci, G; Loglisci, Mg; Ricci, R; Diverio, D; Latagliata, R; Foa, Roberto; Lo Coco, F.
Fludarabine + prednisone alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.
2003 Mauro, Francesca Romana; Zinzani, P; Zaja, F; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, R; Baccarani, M; Tura, S; Mandelli, Franco
Fludarabine and prednisone in pretreated refractory B-chronic lymphocytic leukemia (B-CLL) in advanced stages
1993 G., DE ROSSI; Mauro, Francesca Romana; R., Caruso; B., Monarca; Mandelli, Franco
Fludarabine, Ara-C, Novantrone and Dexamethasone (FAND)in previously treated chronic lymphocitic leukemia patients.
2002 Mauro, Francesca Romana; Foa, Roberto; Meloni, Giovanna; Gentile, M; Giammartini, E; Giannarelli, D; DE PROPRIS, Ms; Rapanotti, Mc; DE FABRITIIS, P; Mandelli, Franco
Fludarabine, cyclophosphamide and lenalidomide (FCL) for previously treatd patients with CLL. GIMEMA study CLL0606.
2011 Mauro, Fr; Armiento, D; Vignetti, M; De Propris, Ms; Nanni, M; Marinelli, M; Frustaci, Am; Orlando, S; Graziosi, A; Molica, M; Carella, Am; DEL GIUDICE, Ilaria; Guarini, A; Foà, R.
Folate status in Italian blood donors: relation to gender and smoking
2000 Cafolla, Arturo; F., Dragoni; Girelli, Gabriella; M. E., Tosti; A., Costante; D., Pastorelli; G., Bedoni; C. S., Scott
FOLLOW UP A LUNGO TERMINE DEI PAZIENTI CON LMC-PH+ IN RISPOSTA CITOGENETICA COMPLETA CON TERAPIA INCLUDENTE INTERFERONE NELL'ERA IMATINIB - PROTOCOLLO GIMEMA CML0509
2012 Russo, D; Alimena, G; Colombi, C; Breccia, M; Soverini, S; Iacobucci, I; Cattina, F; Martinelli, G; Testoni, N; Liberati, Am; Appolloni, V; Tiribelli, M; Fanin, R; Ferrara, F; Annunziata, M; Trabacchi, E; Vallisa, D; De Vivo, A; Castagnetti, F; Fogli, M; Durante, S; Di Raimondo, F; Stagno, F; Carella, Am; Pica, G; Cortelezzi, A; Iurlo, A; Pregno, P; Vitolo, U; Abruzzese, E; De Fabritiis, P; Longinotti, M; Pardini, S; Musolino, C; Russo, S; Gobbi, M; Pierri, I; Gaidano, G; Lunghi, M; Visani, G; Barulli, S; Cazzola, M; Merante, S; Skert, C; Malagola, M; Rosti, G; Mandelli, F; Baccarani, M
FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS
2014 Gugliotta, G; Castagnetti, F; Breccia, M; Levato, L; Fava, C; Luciano, L; Zaccaria, A; Rossi, Ar; Usala, E; Gozzini, A; Vigneri, P; Cedrone, M; Tiribelli, M; Abruzzese, E; Avanzini, P; Palandri, F; Soverini, S; Alimena, G; Pane, F; Martinelli, G; Cavo, M; Saglio, G; Baccarani, M; Rosti, G
Francesco Lo Coco, a distinguished hematologist and a friend
2019 Corradini, P.; Musto, P.; Vignetti, M.
Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome
2008 Palandri, F; Iacobucci, I; Castagnetti, F; Testoni, N; Poerio, A; Amabile, M; Breccia, M; Intermesoli, T; Iuliano, F; Rege-Cambrin, G; Tiribelli, M; Miglino, M; Pane, F; Saglio, G; Martinelli, G; Rosti, G; Baccarani, M
FRONTLINE NILOTINIB 400 MG BID IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: STABLE RESULTS BEYOND 4 YEARS - THE GIMEMA CML WP TRIAL CML0307
2012 Gugliotta, G; Castagnetti, F; Breccia, M; Levato, L; Capucci, A; Tiribelli, M; Zaccaria, A; Bocchia, M; Cuneo, A; Stagno, F; Specchia, G; Musso, M; Martino, B; Cedrone, M; Intermesoli, T; Palandri, F; Soverini, S; Baldazzi, C; Durante, S; Testoni, N; Alimena, G; Pane, F; Saglio, G; Martinelli, G; Baccarani, M; Rosti, G
FRONTLINE TREATMENT OF PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKEMIA WITH SEQUENTIAL ADMINISTRATION OF NILO- TINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY: A PHASE 2 MULTICENTRIC STUDY
2012 Castagnetti, F; Rosti, G; Breccia, M; Stagno, F; Gozzini, A; Specchia, G; Capucci, A; Martino, B; Rege Cambrin, G; Luciano, L; Abruzzese, E; Bocchia, M; Cavazzini, F; Tiribelli, M; Pierri, I; Gugliotta, G; Palandri, F; Durante, S; Soverini, S; Testoni, N; Pane, F; Saglio, G; Alimena, G; Martinelli, G; Baccarani, M
Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells
1998 Daniela, Zarcone; GIULIO DE, Rossi; Claudya, Tenca; Mauro, Francesca Romana; GIANNA M., Cerruti; Nicola, Albi; Stefano, Fiorucci; Andrea, Velardi; CARLO E., Grossi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Failure of late intensification therapy combining cytosine-arabinoside + thioguanine in reduce the risk of relapse off-therapy in childhood acute lymphocitic leukemia (ALL). | 1983 | Meloni, Giovanna; ALOE SPIRITI, Maria Antonietta; S., Amadori; Giona, Fiorina | |
| Fatty acid oxidation and metabolic targeting of leukemia cells by the CPT1 inhibitor ST1326 | 2013 | Mirabilii, Simone; Ricciardi, Maria Rosaria; Allegretti, Matteo; Licchetta, Roberto; M., Vincenzi; G., Peluso; R., Nicolai; Foà, R.; Tafuri, Agostino | |
| Feasibility and safety of a new technique of extracorporeal photochemotherapy: Experience of 240 procedures | 1999 | Perotti, C.; Torretta, L.; Viarengo, G.; Roveda, L.; Bernuzzi, S.; Carbone, S.; Del Fante, C.; La Torre, R.; Locatelli, F.; Bonetti, F.; Gabba, P.; Bellosta, M.; Salvaneschi, L. | |
| Flow cytometric analysis of the TCR V-beta repertoire in mature T-cell expansions. | 2005 | De Propris, Ms; DELLA STARZA, Irene; Milani, L; DEL GIUDICE, Ilaria; Santangelo, S; Anaclerico, B; Calabrese, E; Mancini, F; Foà, R; Guarini, A. | |
| Flow cytometric measurement (H-1 Technicon) of microcytic and hyperchromic red cell populations in pediatric patients affected by hereditary spherocytosis (HS) | 1989 | Ialongo, Pierluigi; Vignetti, Marco; Cigliano, G; Amadori, S; Mandelli, Franco | |
| FLT3 positive acute myeloid leukemia: A single center experience | 2007 | V., Gianfelici; S., Capria; L., Cardarelli; Cimino, Giuseppe; D., Diverio; A. P., Iori; M., Nanni; M., Ribersani; S. M., Trisolini; Foa, Roberto; Meloni, Giovanna | |
| FLT3-ITD ABNORMALITIES AND COMORBIDITIES AS INDEPENDENT PROGNOSTIC INDICATORS OF SURVIVAL IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS | 2009 | Breccia, M; Cannella, L.; Latagliata, R.; Diverio, D.; Minotti, C.; Cartoni, C.; Stefanizzi, C.; Loglisci, G.; Nanni, M.; Cimino, G.; Alimena, G. | |
| FLT3-ITD confers poor prognosis in patients with acute promyelocytic leukemia treated with AIDA protocols: long-term follow-up analysis. | 2013 | Breccia, M; Loglisci, G; Loglisci, Mg; Ricci, R; Diverio, D; Latagliata, R; Foa, Roberto; Lo Coco, F. | |
| Fludarabine + prednisone alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study. | 2003 | Mauro, Francesca Romana; Zinzani, P; Zaja, F; Gentile, M; Vegna, Ml; Stefoni, V; Marin, L; Fanin, R; Baccarani, M; Tura, S; Mandelli, Franco | |
| Fludarabine and prednisone in pretreated refractory B-chronic lymphocytic leukemia (B-CLL) in advanced stages | 1993 | G., DE ROSSI; Mauro, Francesca Romana; R., Caruso; B., Monarca; Mandelli, Franco | |
| Fludarabine, Ara-C, Novantrone and Dexamethasone (FAND)in previously treated chronic lymphocitic leukemia patients. | 2002 | Mauro, Francesca Romana; Foa, Roberto; Meloni, Giovanna; Gentile, M; Giammartini, E; Giannarelli, D; DE PROPRIS, Ms; Rapanotti, Mc; DE FABRITIIS, P; Mandelli, Franco | |
| Fludarabine, cyclophosphamide and lenalidomide (FCL) for previously treatd patients with CLL. GIMEMA study CLL0606. | 2011 | Mauro, Fr; Armiento, D; Vignetti, M; De Propris, Ms; Nanni, M; Marinelli, M; Frustaci, Am; Orlando, S; Graziosi, A; Molica, M; Carella, Am; DEL GIUDICE, Ilaria; Guarini, A; Foà, R. | |
| Folate status in Italian blood donors: relation to gender and smoking | 2000 | Cafolla, Arturo; F., Dragoni; Girelli, Gabriella; M. E., Tosti; A., Costante; D., Pastorelli; G., Bedoni; C. S., Scott | |
| FOLLOW UP A LUNGO TERMINE DEI PAZIENTI CON LMC-PH+ IN RISPOSTA CITOGENETICA COMPLETA CON TERAPIA INCLUDENTE INTERFERONE NELL'ERA IMATINIB - PROTOCOLLO GIMEMA CML0509 | 2012 | Russo, D; Alimena, G; Colombi, C; Breccia, M; Soverini, S; Iacobucci, I; Cattina, F; Martinelli, G; Testoni, N; Liberati, Am; Appolloni, V; Tiribelli, M; Fanin, R; Ferrara, F; Annunziata, M; Trabacchi, E; Vallisa, D; De Vivo, A; Castagnetti, F; Fogli, M; Durante, S; Di Raimondo, F; Stagno, F; Carella, Am; Pica, G; Cortelezzi, A; Iurlo, A; Pregno, P; Vitolo, U; Abruzzese, E; De Fabritiis, P; Longinotti, M; Pardini, S; Musolino, C; Russo, S; Gobbi, M; Pierri, I; Gaidano, G; Lunghi, M; Visani, G; Barulli, S; Cazzola, M; Merante, S; Skert, C; Malagola, M; Rosti, G; Mandelli, F; Baccarani, M | |
| FOUR-YEAR OUTCOME OF 215 NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH NILOTINIB FRONTLINE: A GIMEMA CML WORKING PARTY ANALYSIS | 2014 | Gugliotta, G; Castagnetti, F; Breccia, M; Levato, L; Fava, C; Luciano, L; Zaccaria, A; Rossi, Ar; Usala, E; Gozzini, A; Vigneri, P; Cedrone, M; Tiribelli, M; Abruzzese, E; Avanzini, P; Palandri, F; Soverini, S; Alimena, G; Pane, F; Martinelli, G; Cavo, M; Saglio, G; Baccarani, M; Rosti, G | |
| Francesco Lo Coco, a distinguished hematologist and a friend | 2019 | Corradini, P.; Musto, P.; Vignetti, M. | |
| Front-line treatment of Philadelphia positive chronic myeloid leukemia with imatinib and interferon-alpha: 5-year outcome | 2008 | Palandri, F; Iacobucci, I; Castagnetti, F; Testoni, N; Poerio, A; Amabile, M; Breccia, M; Intermesoli, T; Iuliano, F; Rege-Cambrin, G; Tiribelli, M; Miglino, M; Pane, F; Saglio, G; Martinelli, G; Rosti, G; Baccarani, M | |
| FRONTLINE NILOTINIB 400 MG BID IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA: STABLE RESULTS BEYOND 4 YEARS - THE GIMEMA CML WP TRIAL CML0307 | 2012 | Gugliotta, G; Castagnetti, F; Breccia, M; Levato, L; Capucci, A; Tiribelli, M; Zaccaria, A; Bocchia, M; Cuneo, A; Stagno, F; Specchia, G; Musso, M; Martino, B; Cedrone, M; Intermesoli, T; Palandri, F; Soverini, S; Baldazzi, C; Durante, S; Testoni, N; Alimena, G; Pane, F; Saglio, G; Martinelli, G; Baccarani, M; Rosti, G | |
| FRONTLINE TREATMENT OF PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKEMIA WITH SEQUENTIAL ADMINISTRATION OF NILO- TINIB 400 MG TWICE DAILY AND IMATINIB 400 MG ONCE DAILY: A PHASE 2 MULTICENTRIC STUDY | 2012 | Castagnetti, F; Rosti, G; Breccia, M; Stagno, F; Gozzini, A; Specchia, G; Capucci, A; Martino, B; Rege Cambrin, G; Luciano, L; Abruzzese, E; Bocchia, M; Cavazzini, F; Tiribelli, M; Pierri, I; Gugliotta, G; Palandri, F; Durante, S; Soverini, S; Testoni, N; Pane, F; Saglio, G; Alimena, G; Martinelli, G; Baccarani, M | |
| Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells | 1998 | Daniela, Zarcone; GIULIO DE, Rossi; Claudya, Tenca; Mauro, Francesca Romana; GIANNA M., Cerruti; Nicola, Albi; Stefano, Fiorucci; Andrea, Velardi; CARLO E., Grossi |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile